Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for MediWound (MDWD) over the last 11 years, with Q3 2025 value amounting to $18.0 million.

  • MediWound's Total Non-Current Liabilities rose 2071.44% to $18.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.0 million, marking a year-over-year increase of 2071.44%. This contributed to the annual value of $15.8 million for FY2024, which is 559.77% down from last year.
  • MediWound's Total Non-Current Liabilities amounted to $18.0 million in Q3 2025, which was up 2071.44% from $17.8 million recorded in Q2 2025.
  • In the past 5 years, MediWound's Total Non-Current Liabilities registered a high of $27.0 million during Q4 2022, and its lowest value of $11.4 million during Q1 2023.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $15.8 million (2024), whereas its average is $15.8 million.
  • Per our database at Business Quant, MediWound's Total Non-Current Liabilities surged by 9878.72% in 2022 and then tumbled by 3810.69% in 2023.
  • Over the past 5 years, MediWound's Total Non-Current Liabilities (Quarter) stood at $13.6 million in 2021, then soared by 98.79% to $27.0 million in 2022, then tumbled by 38.11% to $16.7 million in 2023, then decreased by 5.6% to $15.8 million in 2024, then rose by 13.99% to $18.0 million in 2025.
  • Its Total Non-Current Liabilities stands at $18.0 million for Q3 2025, versus $17.8 million for Q2 2025 and $15.9 million for Q1 2025.